Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
StockCIK 1631574

Wave Life Sciences, Inc. (WVE): Insider Trades and Fund Holdings

In the past 12 months, Wave Life Sciences, Inc. insiders reported 0 open-market purchases worth $0 and 4 sales worth $135K; 4 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months
$0Bought by insiders, 12 months
$135KSold by insiders, 12 months
2Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Aug 13, 2026.

Recent WVE insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Aug 13Aug 12Adrian RawcliffeDirectorDirector▼ SELL10b5-112,7005.29$67KAll soldForm 4 ↗
Aug 13Aug 11Heidi L. WagnerDirectorDirector▼ SELL10b5-17,0006.01$42K−14%Form 4 ↗
Aug 13Aug 11Ken TakanashiDirectorDirector▼ SELL10b5-13,8646.01$23K−16%Form 4 ↗
Aug 13Aug 11Aik Na TanDirectorDirector▼ SELL10b5-14326.01$3K−1.7%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Adrian RawcliffeDirector0$01$67KAug 13, 2026
Heidi L. WagnerDirector0$01$42KAug 13, 2026
Ken TakanashiDirector0$01$23KAug 13, 2026
Aik Na TanDirector0$01$3KAug 13, 2026
ADVERTISEMENT
728 × 90 ad slot320 × 100 ad slot

Tracked funds that report WVE

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Renaissance TechnologiesQ2 20261,704,520$9.90M0.01%▲ +185.4%
Duquesne Family OfficeQ2 2026173,000$1K0.02%No change
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →